Clinical efficacy of renal dosing adjustments of ceftazidime–avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: A systematic review and meta‐analysis of observational studies-Reference-Cited by-同舟云学术

Clinical efficacy of renal dosing adjustments of ceftazidime–avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: A systematic review and meta‐analysis of observational studies

Published:2022-11-22 Issue:2 Volume:89 Page:617-629
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Gatti Milo¹²^ORCID,Fornaro Giacomo³,Viale Pierluigi¹³,Pea Federico¹²^ORCID,Giannella Maddalena¹³

Affiliation:

1. Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna Bologna Italy

2. Clinical Pharmacology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

3. Infectious Diseases Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15586

Reference32 articles.

1. Antimicrobial Resistance

2. Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors

3. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II);Expert Review of Anti-infective Therapy;2024-05-27

2. Evaluation of clinical and microbiological factors related to mortality in patients with Gram-negative bacterial infections treated with ceftazidime–avibactam: A prospective multicentric cohort study;Journal of Global Antimicrobial Resistance;2024-03

3. Clinical Outcomes and Risk Factors for Death in Critically Ill Patients with Carbapenem-Resistant Klebsiella pneumoniae Treated with Ceftazidime-Avibactam: A Retrospective Study;Infection and Drug Resistance;2024-01

4. The expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swan;Expert Review of Clinical Pharmacology;2023-10-30

5. Antimicrobial Resistance in Organ Transplant Recipients;Infectious Disease Clinics of North America;2023-09